
Funding received for first Phase III trial of a chikungunya vaccine: June’s industry headlines
Take a look at this month’s industry headlines including an FDA approval for Zebraxa, new…
Take a look at this month’s industry headlines including an FDA approval for Zebraxa, new…
As of September 14th, fourteen confirmed cases of chikungunya have been reported in Italy, specifically in Rome and the coastal area of the Lazio Region.